A Retrospective Analysis of Longitudinal Changes in Bone Mineral Content in Cystic Fibrosis
Overview
Pediatrics
Authors
Affiliations
Background: We aimed to describe the longitudinal changes in bone mineral content and influencing factors, in children with cystic fibrosis (CF).
Methods: One hundred children (50 females) had dual X-ray absorptiometry (DXA) performed. Of these, 48 and 24 children had two to three scans, respectively over 10 years of follow-up. DXA data were expressed as lumbar spine bone mineral content standard deviation score (LSBMCSDS) adjusted for age, gender, ethnicity and bone area. Markers of disease, anthropometry and bone biochemistry were collected retrospectively.
Results: Baseline LSBMCSDS was >0.5 SDS in 13% children, between -0.5; 0.5 SDS, in 50% and ≤-0.5 in the remainder. Seventy-eight percent of the children who had baseline LSBMCSDS >-0.5, and 35% of the children with poor baseline (LSBMCSDS<-0.5), showed decreasing values in subsequent assessments. However, mean LS BMC SDS did not show a significant decline in subsequent assessments (-0.51; -0.64; -0.56; p=0.178). Lower forced expiratory volume in 1 s percent (FEV1%) low body mass index standard deviation scores (BMI SDS) and vitamin D were associated with reduction in BMC.
Conclusions: Bone mineral content as assessed by DXA is sub-optimal and decreases with time in most children with CF and this study has highlighted parameters that can be addressed to improve bone health.
Vitamin D deficiency in patients with cystic fibrosis: a systematic review and meta-analysis.
Farahbakhsh N, Fatahi S, Shirvani A, Motaharifard M, Mohkam M, Tabatabaii S J Health Popul Nutr. 2024; 43(1):11.
PMID: 38233891 PMC: 10795301. DOI: 10.1186/s41043-024-00499-2.
An update on methods for assessing bone quality and health in Cystic fibrosis.
Williams K, Darukhanavala A, Hicks R, Kelly A J Clin Transl Endocrinol. 2022; 27:100281.
PMID: 34984171 PMC: 8693345. DOI: 10.1016/j.jcte.2021.100281.
A Clinician's guide to vitamin D supplementation for patients with cystic fibrosis.
Wood C, Hasan S, Darukhanavala A, Tangpricha V J Clin Transl Endocrinol. 2021; 26:100273.
PMID: 34815946 PMC: 8593649. DOI: 10.1016/j.jcte.2021.100273.